LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer

UTRECT, The Netherlands and PHILADELPHIA, Feb. 06, 2023 -- LAVA Therapeutics N.V. , an immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific... | February 6, 2023

Related Keywords

United Kingdom ,United States ,Netherlands ,Russia ,London ,City Of ,Philadelphia ,Pennsylvania ,Ukraine ,Benjamin Winograd ,Charles Morris ,Allos Therapeutics ,Linkedin ,Twitter ,Astrazeneca ,Youtube ,Radius Health ,Sheffield University Medical School ,Morris ,Stephen Hurly ,Celyad Oncology ,Psioxus Therapeutics ,Medical Science ,Clinical Pharmacology ,Royal College ,Lava Therapeuticsnv Stock Exchange ,News ,Information ,Press Release ,The ,End ,023 ,Lava ,Herapeutics ,N ,Company ,Ocused ,Developing ,Its ,Roprietary ,Platform ,F Lvtx Nl0015000ag6 ,